5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | NEUTRAL | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.83▲ | 3.74▲ | 3.76▲ | 3.98▼ | 3.83▲ |
MA10 | 3.75▲ | 3.78▲ | 3.84▲ | 3.91▲ | 3.88▲ |
MA20 | 3.84▲ | 3.90▲ | 3.93▲ | 3.82▲ | 4.11▼ |
MA50 | 4.25▼ | 4.48▼ | 4.69▼ | 3.88▲ | 4.14▼ |
MA100 | 4.82▼ | 4.54▼ | 4.48▼ | 4.21▼ | 4.49▼ |
MA200 | 4.47▼ | 4.30▼ | 4.37▼ | 4.34▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.068▲ | 0.048▲ | 0.036▲ | 0.026▲ | -0.013▼ |
RSI | 53.745▲ | 50.869▲ | 49.545▼ | 53.386▲ | 47.747▼ |
STOCH | 54.904 | 27.805 | 27.945 | 63.009 | 30.245 |
WILL %R | -19.490▲ | -19.490▲ | -31.766 | -34.722 | -57.718 |
CCI | 127.497▲ | 120.273▲ | 76.343 | 60.159 | 16.573 |
Tuesday, April 15, 2025 02:17 AM
Pierluigi Paracchi , CEO Genenta Science (Nasdaq: GNTA), a pioneer in immuno-oncology and a leader in cell-based therapeutics, will present at “Montalcini Global Biotech Tour” in Doha ...
|
Monday, April 14, 2025 10:01 PM
MILAN and NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Pierluigi Paracchi, CEO Genenta Science (Nasdaq: GNTA), a pioneer in immuno-oncology and a leader in cell-based therapeutics, will present at ...
|
Monday, April 14, 2025 10:01 PM
MILAN and NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Pierluigi Paracchi , CEO Genenta Science (Nasdaq: GNTA), a pioneer in immuno-oncology and a leader in cell-based therapeutics, will present at ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 3.96 | 4.07 | 3.82 | 3.97 | 5,462 |
30/04/25 | 4.06 | 4.06 | 3.88 | 3.89 | 1,278 |
28/04/25 | 4.10 | 4.15 | 4.08 | 4.08 | 2,624 |
25/04/25 | 4.19 | 4.19 | 3.89 | 4.04 | 4,139 |
24/04/25 | 3.76 | 4.22 | 3.76 | 3.92 | 11,707 |
23/04/25 | 3.60 | 4.00 | 3.60 | 3.83 | 9,282 |
22/04/25 | 3.8631 | 3.8631 | 3.745 | 3.745 | 1,680 |
21/04/25 | 3.62 | 4.11 | 3.51 | 3.87 | 14,252 |
17/04/25 | 3.83 | 4.03 | 3.61 | 3.88 | 10,199 |
16/04/25 | 3.77 | 3.9138 | 3.54 | 3.8789 | 4,974 |
|
|
||||
|
|
||||
|
|